Karin Bauer

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Systemic Mastocytosis, KIT and the Effects of KIT Tyrosine Kinase Inhibitors on Mast Cell and Basophil Activation.

Systemic Mastocytosis, KIT and the Effects of KIT Tyrosine Kinase Inhibitors on Mast Cell and Basophil Activation.

Journal: Current allergy and asthma reports

Published: October 05, 2025

BRD4 degraders may effectively counteract therapeutic resistance of leukemic stem cells in AML and ALL.

BRD4 degraders may effectively counteract therapeutic resistance of leukemic stem cells in AML and ALL.

Journal: American journal of hematology

Published: January 30, 2024

CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS.

CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS.

Journal: Leukemia

Published: May 02, 2023

Antineoplastic efficacy profiles of avapritinib and nintedanib in KIT D816V+ systemic mastocytosis: a preclinical study.

Antineoplastic efficacy profiles of avapritinib and nintedanib in KIT D816V+ systemic mastocytosis: a preclinical study.

Journal: American journal of cancer research

Published: June 29, 2022

BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph+ chronic myeloid leukemia.

BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph+ chronic myeloid leukemia.

Journal: American journal of hematology

Published: March 08, 2022

CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V+ Neoplastic Mast Cells.

CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V+ Neoplastic Mast Cells.

Journal: Cancers

Published: December 31, 2021

PI3-kinase inhibition as a strategy to suppress the leukemic stem cell niche in Ph+ chronic myeloid leukemia.

PI3-kinase inhibition as a strategy to suppress the leukemic stem cell niche in Ph+ chronic myeloid leukemia.

Journal: American journal of cancer research

Published: August 05, 2021

Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosis.

Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosis.

Journal: Neoplasia (New York, N.Y.)

Published: June 25, 2021

Phenotypic characterization of leukemia-initiating stem cells in chronic myelomonocytic leukemia.

Phenotypic characterization of leukemia-initiating stem cells in chronic myelomonocytic leukemia.

Journal: Leukemia

Published: November 13, 2020

Degradation of BRD4 - a promising treatment approach not only for hematologic but also for solid cancer.

Degradation of BRD4 - a promising treatment approach not only for hematologic but also for solid cancer.

Journal: American journal of cancer research

Published: September 17, 2020

Cell-based and antibody-mediated immunotherapies directed against leukemic stem cells in acute myeloid leukemia: Perspectives and open issues.

Cell-based and antibody-mediated immunotherapies directed against leukemic stem cells in acute myeloid leukemia: Perspectives and open issues.

Journal: Stem cells translational medicine

Published: April 08, 2020

Plectin dysfunction in neurons leads to tau accumulation on microtubules affecting neuritogenesis, organelle trafficking, pain sensitivity and memory.

Plectin dysfunction in neurons leads to tau accumulation on microtubules affecting neuritogenesis, organelle trafficking, pain sensitivity and memory.

Journal: Neuropathology and applied neurobiology

Published: November 20, 2019

Showing 1-12 of 23

Last Updated: 09/26/2026